28108610|t|Circulating CXCR5 + PD-1 + ICOS + Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies
28108610|a|Although type 1 diabetes (T1D) is primarily perceived as a T cell -driven autoimmune disease, islet autoantibodies are the best currently available biomarker for autoimmunity and disease risk. These antibodies are produced by autoreactive B cells, the activation of which is largely dependent on the function of CD4 (+) CXCR5 (+) follicular T helper cells (Tfh). In this study, we have comprehensively characterized the Tfh - as well as B-cell compartments in a large cohort of children with newly diagnosed T1D or at different stages of preclinical T1D. We demonstrate that the frequency of CXCR5 (+) PD-1 (+) ICOS (+)- activated circulating Tfh cells is increased both in children with newly diagnosed T1D and in autoantibody -positive at-risk children with impaired glucose tolerance. Interestingly, this increase was only evident in children positive for two or more biochemical autoantibodies. No alterations in the circulating B-cell compartment were observed in children with either prediabetes or diabetes. Our results demonstrate that Tfh activation is detectable in the peripheral blood close to the presentation of clinical T1D but only in a subgroup of children identifiable by positivity for multiple autoantibodies. These findings suggest a role for Tfh cells in the pathogenesis of human T1D and carry important implications for targeting Tfh cells and/or B cells therapeutically.
28108610	0	11	Circulating	T169	C0175630
28108610	12	17	CXCR5	T116,T192	C0300729
28108610	20	24	PD-1	T116,T123	C0135710
28108610	27	31	ICOS	T116,T129	C1570399
28108610	34	44	Follicular	T023	C1571705
28108610	45	59	T Helper Cells	T025	C0018894
28108610	87	96	Diagnosis	T062	C1704656
28108610	100	115	Type 1 Diabetes	T047	C0011854
28108610	119	127	Children	T100	C0008059
28108610	133	156	Multiple Autoantibodies	T033	C1855872
28108610	166	181	type 1 diabetes	T047	C0011854
28108610	183	186	T1D	T047	C0011854
28108610	216	222	T cell	T025	C0039194
28108610	231	249	autoimmune disease	T047	C0004364
28108610	251	256	islet	T025	C1522529
28108610	257	271	autoantibodies	T116,T129	C0004358
28108610	305	314	biomarker	T201	C0005516
28108610	319	331	autoimmunity	T046	C0004368
28108610	336	348	disease risk	T033	C1281905
28108610	356	366	antibodies	T116,T129	C0003241
28108610	383	395	autoreactive	T080	C0205332
28108610	396	403	B cells	T025	C0004561
28108610	409	419	activation	T043	C2259068
28108610	457	465	function	T169	C0542341
28108610	469	472	CD4	T116,T129,T192	C0003323
28108610	477	482	CXCR5	T116,T192	C0300729
28108610	487	497	follicular	T023	C1571705
28108610	498	512	T helper cells	T025	C0018894
28108610	514	517	Tfh	T025	C0018894
28108610	528	533	study	T062	C2603343
28108610	543	558	comprehensively	T080	C1880156
28108610	559	572	characterized	T052	C1880022
28108610	577	580	Tfh	T025	C0018894
28108610	594	600	B-cell	T025	C0004561
28108610	601	613	compartments	T017	C2349967
28108610	625	631	cohort	T098	C0599755
28108610	635	643	children	T100	C0008059
28108610	655	664	diagnosed	T033	C0011900
28108610	665	668	T1D	T047	C0011854
28108610	685	691	stages	T079	C1306673
28108610	695	706	preclinical	T080	C1709630
28108610	707	710	T1D	T047	C0011854
28108610	715	726	demonstrate	T060	C2729318
28108610	736	745	frequency	T081	C0871396
28108610	749	754	CXCR5	T116,T192	C0300729
28108610	759	763	PD-1	T116,T123	C0135710
28108610	768	772	ICOS	T116,T129	C1570399
28108610	778	787	activated	T033	C1867034
28108610	788	799	circulating	T169	C0175630
28108610	800	809	Tfh cells	T025	C0018894
28108610	831	839	children	T100	C0008059
28108610	851	860	diagnosed	T033	C0011900
28108610	861	864	T1D	T047	C0011854
28108610	872	884	autoantibody	T116,T129	C0004358
28108610	895	902	at-risk	T080	C1444641
28108610	903	911	children	T100	C0008059
28108610	926	943	glucose tolerance	T039	C0178665
28108610	994	1002	children	T100	C0008059
28108610	1028	1039	biochemical	T169	C0205474
28108610	1040	1054	autoantibodies	T116,T129	C0004358
28108610	1078	1089	circulating	T169	C0175630
28108610	1090	1096	B-cell	T025	C0004561
28108610	1097	1108	compartment	T017	C2349967
28108610	1114	1122	observed	T169	C1441672
28108610	1126	1134	children	T100	C0008059
28108610	1147	1158	prediabetes	T047	C0362046
28108610	1162	1170	diabetes	T047	C0011847
28108610	1176	1183	results	T033	C0683954
28108610	1184	1195	demonstrate	T060	C2729318
28108610	1201	1204	Tfh	T025	C0018894
28108610	1205	1215	activation	T052	C1879547
28108610	1219	1229	detectable	T201	C3830527
28108610	1237	1253	peripheral blood	T031	C0229664
28108610	1283	1291	clinical	T080	C0205210
28108610	1292	1295	T1D	T047	C0011854
28108610	1322	1330	children	T100	C0008059
28108610	1331	1343	identifiable	T080	C0205396
28108610	1362	1385	multiple autoantibodies	T033	C1855872
28108610	1393	1401	findings	T033	C0243095
28108610	1421	1430	Tfh cells	T025	C0018894
28108610	1438	1450	pathogenesis	T046	C0699748
28108610	1454	1459	human	T016	C0086418
28108610	1460	1463	T1D	T047	C0011854
28108610	1484	1496	implications	T058	C0509640
28108610	1501	1510	targeting	T043	C0599894
28108610	1511	1520	Tfh cells	T025	C0018894
28108610	1528	1535	B cells	T025	C0004561
28108610	1536	1551	therapeutically	T061	C0087111